What is the Incorporation or founding date of Stem Cell Cure India Private Limited?

Stem Cell Cure India Private Limited was incorporated on 18 Apr 2017.

What is authorized share capital and paid-up capital of Stem Cell Cure India Private Limited?

The authorized share capital of Stem Cell Cure India Private Limited is ₹ 100000.0 and paid-up capital is ₹ 100000.0.

Who are the current board members & directors of Stem Cell Cure India Private Limited?

Currently 2 directors are associated with Stem Cell Cure India Private Limited. Prashant Tyagi And Tanu.

What is the registered address of Stem Cell Cure India Private Limited?

As per Ministry of Corporate Affairs (Mca), the registered address of Stem Cell Cure India Private Limited is H No. E-486 Gali No-9, West Vinod Nagar India, Delhi, 110092.

What is the corporate identification number (CIN) and company number of Stem Cell Cure India Private Limited?

The corporate identification number (CIN) of Stem Cell Cure India Private Limited is U74999DL2017PTC316237 and the company number is 316237 as per Ministry of Corporate Affairs (MCA).

What has been the recent revenue trend for Stem Cell Cure India Private Limited?

According to the financial reports for the fiscal year 2022, the revenue trend for Stem Cell Cure India Private Limited has risen by 2.98%.

What change has been observed in the net worth of Stem Cell Cure India Private Limited, and by what percentage?

The financial reports for the fiscal year 2022 indicates that The net worth of Stem Cell Cure India Private Limited has experienced an upsurge of 16.79%.

When was the last Balance Sheet of Stem Cell Cure India Private Limited filed with the ROC?

The most recent Balance Sheet for Stem Cell Cure India Private Limited was filed with the ROC on 31 Mar 2024.

Stem Cell Cure India Private Limited

Stem Cell Cure India Profile

Key Indicators

Authorised Capital ₹ 0.10 M as on 15-12-2024
Paid Up Capital ₹ 0.10 M as on 15-12-2024
Company Age 7 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Revenue Growth 2.98% (FY 2022)
Profit Growth -6.25% (FY 2022)
Ebitda -2197.91% (FY 2022)
Net Worth 16.79% (FY 2022)
Total Assets -56.73% (FY 2022)

About Stem Cell Cure India

Stem Cell Cure India Private Limited (SCCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2017 (Seven years and nine months 30 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Tanu and Prashant Tyagi serve as directors at the Company.

Company Details

Location
Delhi, India
Telephone
+91-XXXXXXXXXX
Email Address
Website
-
Social Media

-

Corporate Identity Details

CIN/LLPIN
U74999DL2017PTC316237
Company No.
316237
Company Classification
Private Limited Indian Non-Government Company
Incorporation Date
18 Apr 2017
Date of AGM
28 Aug 2024
Date of Balance Sheet
31 Mar 2024
Listing Status
Unlisted
ROC Code
Roc Delhi

Industry

Healthcare

Who are the key members and board of directors at Stem Cell Cure India?

Board Members (2)

Name	Designation	Appointment Date	Status
Tanu	Director	01-Jun-2018	Current
Prashant Tyagi	Director	18-Apr-2017	Current

Financial Performance of Stem Cell Cure India.

Stem Cell Cure India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.98% increase. The company also saw a slight decrease in profitability, with a 6.25% decrease in profit. The company's net worth Soared by an impressive increase of 16.79%.

Graph illustrating revenue growth over time

Graph showing profit and loss trends over time

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

2.98%

Revenue from Operations

-48.40%

Total Assets

-56.73%

Profit or Loss

-6.25%

Net Worth

16.79%

EBITDA

-2197.91%

What is the Ownership and Shareholding Structure of Stem Cell Cure India?

In 2019, Stem Cell Cure India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)

There are no open charges registered against the company as per our records.

How Many Employees Work at Stem Cell Cure India?

Unlock and access historical data on people associated with Stem Cell Cure India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stem Cell Cure India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stem Cell Cure India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Stem Cell Cure India Private Limited